Andrés Fernando Rodríguez-GutiérrezCamilo Andrés Duarte-CalderónSergio Moreno2026-03-222026-03-22202410.52787/agl.v54i1.390https://doi.org/10.52787/agl.v54i1.390https://andeanlibrary.org/handle/123456789/53432Citaciones: 1<i>Elevated transaminases and total bilirubin levels are frequent findings in patients with COVID-19 and hypoxemia. Aspartate aminotransferase and total bilirrubin were predictive of mortality in these patients, so their measurement on admission is a reasonable practice. Progress needs to be made in incorporating these markers into predictive models of mortality and clinical decision rules.</i>enBilirubinMedicineInternal medicineGastroenterologyAlanine transaminaseLactate dehydrogenaseLymphocyteCohortRetrospective cohort studyMortality ratearticle